Cargando…

High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis

OBJECTIVES: Non-adherence to therapy is an important cause of suboptimal blood pressure control but few practical tools exist to accurately and routinely detect it. We used a simple urine-based assay to evaluate the prevalence of antihypertensive treatment non-adherence and its impact on blood press...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomaszewski, Maciej, White, Christobelle, Patel, Prashanth, Masca, Nicholas, Damani, Ravi, Hepworth, Joanne, Samani, Nilesh J, Gupta, Pankaj, Madira, Webster, Stanley, Adrian, Williams, Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033175/
https://www.ncbi.nlm.nih.gov/pubmed/24694797
http://dx.doi.org/10.1136/heartjnl-2013-305063
_version_ 1782317779780632576
author Tomaszewski, Maciej
White, Christobelle
Patel, Prashanth
Masca, Nicholas
Damani, Ravi
Hepworth, Joanne
Samani, Nilesh J
Gupta, Pankaj
Madira, Webster
Stanley, Adrian
Williams, Bryan
author_facet Tomaszewski, Maciej
White, Christobelle
Patel, Prashanth
Masca, Nicholas
Damani, Ravi
Hepworth, Joanne
Samani, Nilesh J
Gupta, Pankaj
Madira, Webster
Stanley, Adrian
Williams, Bryan
author_sort Tomaszewski, Maciej
collection PubMed
description OBJECTIVES: Non-adherence to therapy is an important cause of suboptimal blood pressure control but few practical tools exist to accurately and routinely detect it. We used a simple urine-based assay to evaluate the prevalence of antihypertensive treatment non-adherence and its impact on blood pressure in a specialist hypertension centre. METHODS: 208 hypertensive patients (125 new referrals, 66 follow-up patients with inadequate blood pressure control and 17 renal denervation referrals) underwent assessment of antihypertensive drug intake using high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis at the time of clinical appointment. A total of 40 most commonly prescribed antihypertensive medications (or their metabolites) were screened for in spot urine samples. RESULTS: Overall, 25% of patients were totally or partially non-adherent to antihypertensive treatment (total non-adherence 10.1%, partial non-adherence 14.9%). The highest prevalence of partial and total non-adherence was among follow-up patients with inadequate blood pressure control (28.8%) and those referred for consideration of renal denervation (23.5%), respectively. There was a linear relationship between blood pressure and the numerical difference in detected/prescribed antihypertensive medications—every unit increase in this difference was associated with 3.0 (1.1) mm Hg, 3.1 (0.7) mm Hg and 1.9 (0.7) mm Hg increase in adjusted clinic systolic blood pressure, clinic diastolic blood pressure (DBP) and 24 h mean daytime DBP (p=0.0051, p=8.62×10(−6), p=0.0057), respectively. CONCLUSIONS: Non-adherence to blood pressure lowering therapy is common, particularly in patients with suboptimal blood pressure control and those referred for renal denervation. HP LC-MS/MS urine analysis could be used to exclude non-adherence and better stratify further investigations and intervention.
format Online
Article
Text
id pubmed-4033175
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-40331752014-06-05 High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis Tomaszewski, Maciej White, Christobelle Patel, Prashanth Masca, Nicholas Damani, Ravi Hepworth, Joanne Samani, Nilesh J Gupta, Pankaj Madira, Webster Stanley, Adrian Williams, Bryan Heart Cardiac Risk Factors and Prevention OBJECTIVES: Non-adherence to therapy is an important cause of suboptimal blood pressure control but few practical tools exist to accurately and routinely detect it. We used a simple urine-based assay to evaluate the prevalence of antihypertensive treatment non-adherence and its impact on blood pressure in a specialist hypertension centre. METHODS: 208 hypertensive patients (125 new referrals, 66 follow-up patients with inadequate blood pressure control and 17 renal denervation referrals) underwent assessment of antihypertensive drug intake using high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis at the time of clinical appointment. A total of 40 most commonly prescribed antihypertensive medications (or their metabolites) were screened for in spot urine samples. RESULTS: Overall, 25% of patients were totally or partially non-adherent to antihypertensive treatment (total non-adherence 10.1%, partial non-adherence 14.9%). The highest prevalence of partial and total non-adherence was among follow-up patients with inadequate blood pressure control (28.8%) and those referred for consideration of renal denervation (23.5%), respectively. There was a linear relationship between blood pressure and the numerical difference in detected/prescribed antihypertensive medications—every unit increase in this difference was associated with 3.0 (1.1) mm Hg, 3.1 (0.7) mm Hg and 1.9 (0.7) mm Hg increase in adjusted clinic systolic blood pressure, clinic diastolic blood pressure (DBP) and 24 h mean daytime DBP (p=0.0051, p=8.62×10(−6), p=0.0057), respectively. CONCLUSIONS: Non-adherence to blood pressure lowering therapy is common, particularly in patients with suboptimal blood pressure control and those referred for renal denervation. HP LC-MS/MS urine analysis could be used to exclude non-adherence and better stratify further investigations and intervention. BMJ Publishing Group 2014-06-01 2014-04-03 /pmc/articles/PMC4033175/ /pubmed/24694797 http://dx.doi.org/10.1136/heartjnl-2013-305063 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Cardiac Risk Factors and Prevention
Tomaszewski, Maciej
White, Christobelle
Patel, Prashanth
Masca, Nicholas
Damani, Ravi
Hepworth, Joanne
Samani, Nilesh J
Gupta, Pankaj
Madira, Webster
Stanley, Adrian
Williams, Bryan
High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
title High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
title_full High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
title_fullStr High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
title_full_unstemmed High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
title_short High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
title_sort high rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (hp lc-ms/ms) urine analysis
topic Cardiac Risk Factors and Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033175/
https://www.ncbi.nlm.nih.gov/pubmed/24694797
http://dx.doi.org/10.1136/heartjnl-2013-305063
work_keys_str_mv AT tomaszewskimaciej highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT whitechristobelle highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT patelprashanth highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT mascanicholas highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT damaniravi highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT hepworthjoanne highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT samaninileshj highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT guptapankaj highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT madirawebster highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT stanleyadrian highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis
AT williamsbryan highratesofnonadherencetoantihypertensivetreatmentrevealedbyhighperformanceliquidchromatographytandemmassspectrometryhplcmsmsurineanalysis